
Explore a 17-minute conference talk on translational pharmacokinetic/pharmacodynamic (PK/PD) modeling in oncology, with a specific focus on targeted protein degradation. Delivered by Colin Phipps from AbbVie Inc. on September 23, 2024, this presentation…

Explore a 15-minute conference talk on accelerating solid tumour therapy development through Quantitative Systems Pharmacology (QSP). Delivered by Cameron Meaney from Simulations Plus Inc, this presentation is part of the Frontiers in Computational and M…

Explore Recursion's groundbreaking biological foundation model, revolutionizing drug discovery through advanced infrastructure, data management, and large-scale training techniques.

Explore cutting-edge spline-switching antisense oligonucleotides as a novel therapeutic approach for disease treatment. Gain insights into this innovative molecular technique and its potential medical applications.

Explore diffusion models for high-dimensional generative optimization in AI, focusing on biomedical applications and machine learning advancements.

Explore NIMHD's efforts to address health disparities, improve minority health, and reduce inequities. Learn about integrating social, environmental, and genomic data for achieving health equity.

Explore AI innovations advancing clinical care, from theoretical foundations to practical therapeutic applications in biomedical research and healthcare.

Explore machine learning's role in optimization and discovery with Andreas Krause. Gain insights into biomedical applications and foundational ML advances in this joint colloquium series.

Explore AI-driven drug design techniques for optimizing pharmacokinetics and ADME with Novartis Principal Scientist Raquel Rodríguez Pérez at the Broad Institute symposium.

Explore programmable generative protein design with Gevorg Grigoryan, CTO of Generate Biomedicines, in this symposium talk on machine learning in drug discovery.

Explore genetic diversity's impact on cell line models and CRISPR tools. Learn how increasing diversity enhances scientific insights and translational benefits for equitable biomedical research.

Explore automated molecule design using retrieval-augmented generative language models in drug discovery, presented by Andrew White from the University of Rochester.

Explore interpretable machine learning techniques for model oversight and gaining valuable insights with Finale Doshi-Velez in this colloquium on AI applications in biomedicine.

Explore AI's role in drug discovery with Sanofi-Aventis scientist Christoph Grebner, discussing key success factors and industry insights.

Explore data-driven approaches to decode biology and revolutionize drug discovery with insights from Recursion's AI and Digital Sciences expert.

Explore machine learning applications in drug discovery with Daphne Koller's keynote on translatable targets and biomarkers at the Broad Institute Symposium.

Explore AI's role in drug discovery, from property prediction to molecular design, with Pfizer's Head of Machine Learning Research.

Explore PROTPARDELLE, an all-atom protein generative model, presented by Stanford's Possu Huang at the Broad Institute's Machine Learning in Drug Discovery Symposium.

Explore industry insights and their academic applications in translational neuroscience fellowships at MGH, focusing on key lessons and practical implications.

Explore ALS research updates, focusing on Expanded Access Protocols. Learn about ongoing and upcoming EAPs, including Pridopidine and RAPA-501, with insights from Dr. Suma Babu.

Explore the science behind ABBV-CLS-7262, an investigational ALS treatment in the HEALEY Platform Trial. Learn from experts about its mechanism of action and potential impact on ALS research.